ArticleResearch square2024

Circulating Tumor Reactive KIR+CD8+ T cells Suppress Anti-Tumor Immunity in Patients with Melanoma.

David Hafler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.